verapamil has been researched along with Tachycardia, Supraventricular in 183 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Tachycardia, Supraventricular: A generic expression for any tachycardia that originates above the BUNDLE OF HIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The efficacy of catheter ablation from the noncoronary aortic cusp (NCC) of verapamil-sensitive atrial tachycardia arising near the atrioventricular node (AVN-AT) has yet to be fully clarified." | 8.12 | Efficacy of catheter ablation from the noncoronary aortic cusp of verapamil-sensitive atrial tachycardia arising near the atrioventricular node. ( Fukami, Y; Fukuoka, R; Haraguchi, K; Hirai, K; Kajiyama, K; Kawasaki, T; Koga, H; Okonogi, T; Orita, Y; Soejima, T; Umeji, K; Yamabe, H, 2022) |
| "Verapamil-sensitive atrial tachycardia originating from the atrioventricular node vicinity (AVN-AT) can be eliminated with radiofrequency energy (RF) deliveries targeting either the entrance or exit of its reentry circuit." | 8.02 | Comparison of the catheter ablation outcome in patients between targeting the entrance and exit of the reentry circuit in verapamil-sensitive atrial tachycardia originating from the atrioventricular-node vicinity. ( Fukami, Y; Fukuoka, R; Haraguchi, K; Hirai, K; Kajiyama, K; Kawasaki, T; Koga, H; Okonogi, T; Orita, Y; Soejima, T; Umeji, K; Yamabe, H, 2021) |
| "Adenosine versus Verapamil and other Antiarrhythmic Drugs: Paroxysmal supraventricular tachycardia is the most common sustained arrhythmia during pregnancy." | 7.69 | [Paroxysmal supraventricular tachycardia in pregnancy. Value of adenosine and other anti-arrhythmia agents]. ( Hösl, P; Johannigmann, J; Rust, M; Schmidt, G, 1996) |
| "In the absence of myocardial ischaemia, ventricular tachycardias occurring in patients with structural heart disease rarely respond to calcium antagonists like verapamil." | 7.68 | Verapamil and ventricular tachycardias. ( Chow, WH; Lau, CP; Tai, YT; Yau, CC, 1991) |
| "Intravenous verapamil is effective in the acute termination of supraventricular tachycardia but is also used for broad-complex tachycardia when the diagnosis is uncertain." | 7.67 | Misuse of intravenous verapamil in patients with ventricular tachycardia. ( Cobbe, SM; Rae, AP; Rankin, AC, 1987) |
| "In a 67-year-old man with multiple myocardial infarctions in the past, the use of oral verapamil for control of angina pectoris was followed by the appearance of two previously undiagnosed abnormalities, namely, a dual-pathway AV node conduction pattern, and paroxysms of AV nodal reentrant tachycardia precipitated by premature ventricular beats (PVB)." | 7.67 | Verapamil-mediated atrioventricular nodal reentrant tachycardia and the uncovering of dual-pathway AV nodal conduction. ( Massumi, RA; Udhoji, VN, 1988) |
| "Verapamil caused a lower ventricular rate, but only six (19%) of the patients (n = 31) converted to sinus rhythm within 4 h (p < 0." | 6.67 | The effect of magnesium versus verapamil on supraventricular arrhythmias. ( Birkeland, K; Gullestad, L; Høyer, MM; Kjekshus, J; Mølstad, P; Vanberg, P, 1993) |
| "SVT complicated by hypotension has been considered a relative contraindication for the use of IV verapamil." | 5.28 | Supraventricular tachyarrhythmias and rate-related hypotension: cardiovascular effects and efficacy of intravenous verapamil. ( Haynes, BE; Haynes, KS; Niemann, JT, 1990) |
| "Moderate-quality evidence shows no differences in effects of adenosine and calcium channel antagonists for treatment of SVT on reverting to sinus rhythm, and low-quality evidence suggests no appreciable differences in the incidence of hypotension." | 4.95 | Adenosine versus intravenous calcium channel antagonists for supraventricular tachycardia. ( Alabed, S; Atallah, E; Chico, TJ; Providencia, R; Qintar, M; Sabouni, A, 2017) |
| "The efficacy of catheter ablation from the noncoronary aortic cusp (NCC) of verapamil-sensitive atrial tachycardia arising near the atrioventricular node (AVN-AT) has yet to be fully clarified." | 4.12 | Efficacy of catheter ablation from the noncoronary aortic cusp of verapamil-sensitive atrial tachycardia arising near the atrioventricular node. ( Fukami, Y; Fukuoka, R; Haraguchi, K; Hirai, K; Kajiyama, K; Kawasaki, T; Koga, H; Okonogi, T; Orita, Y; Soejima, T; Umeji, K; Yamabe, H, 2022) |
| "Verapamil-sensitive atrial tachycardia originating from the atrioventricular node vicinity (AVN-AT) can be eliminated with radiofrequency energy (RF) deliveries targeting either the entrance or exit of its reentry circuit." | 4.02 | Comparison of the catheter ablation outcome in patients between targeting the entrance and exit of the reentry circuit in verapamil-sensitive atrial tachycardia originating from the atrioventricular-node vicinity. ( Fukami, Y; Fukuoka, R; Haraguchi, K; Hirai, K; Kajiyama, K; Kawasaki, T; Koga, H; Okonogi, T; Orita, Y; Soejima, T; Umeji, K; Yamabe, H, 2021) |
| " This may be explained by the inconsistent efficacy of Mg2+, partly in relationship to a given plasma Mg(2+)-concentration, partly caused by the uncertainty regarding the dosage and injection rate or the unawareness of the clinical effects of the cation." | 3.78 | [Clinico-electrophysiologic effects of magnesium, especially in supraventricular tachycardia]. ( Vester, EG, 1997) |
| "The present report describes an unusual case of pulmonary edema after adenosine cardioversion of a supraventricular tachycardia." | 3.73 | Pulmonary edema post-cardioversion: a potential calcium signalling problem. ( Armstrong, PW; Choy, JB; Gulamhusein, S; Hersi, A; Kavanagh, KM, 2006) |
| "Population pharmacokinetic analyses were performed on data from 186 patients with hypertension, coronary artery disease, or supraventricular arrhythmias who were receiving long-term sustained-release oral racemic verapamil (Covera SR in 105 patients, Calan SR in 67 patients, and other formulations in 14 patients; mean +/- SD dose, 280 +/- 139 mg) for clinical care or as a part of phase III efficacy studies." | 3.72 | Population analyses of sustained-release verapamil in patients: effects of sex, race, and smoking. ( Gupta, SK; Kang, D; Krecic-Shepard, ME; Modi, NB; Schwartz, JB; Verotta, D, 2003) |
| "Adenosine versus Verapamil and other Antiarrhythmic Drugs: Paroxysmal supraventricular tachycardia is the most common sustained arrhythmia during pregnancy." | 3.69 | [Paroxysmal supraventricular tachycardia in pregnancy. Value of adenosine and other anti-arrhythmia agents]. ( Hösl, P; Johannigmann, J; Rust, M; Schmidt, G, 1996) |
| " After 24-hour Holter ECG monitoring had revealed Wolff-Parkinson-White syndrome as cause of the PSVT, propafenone was administered (15 mg/kg daily) and has prevented further recurrence of the tachycardia." | 3.69 | [Adenosine triphosphate for supraventricular tachycardia in newborns and suckling infants]. ( Gessler, P; Haas, NA; König, SA; Pufahl, C; Teufel, M, 1994) |
| "In the absence of myocardial ischaemia, ventricular tachycardias occurring in patients with structural heart disease rarely respond to calcium antagonists like verapamil." | 3.68 | Verapamil and ventricular tachycardias. ( Chow, WH; Lau, CP; Tai, YT; Yau, CC, 1991) |
| "Nineteen consecutive patients with atrial fibrillation/flutter or other types of supraventricular tachycardia were given intravenous (IV) calcium salts (1 g) followed by verapamil infusion at a rate of 1 mg/min." | 3.68 | Short-term control of supraventricular tachycardia with verapamil infusion and calcium pretreatment. ( Barnett, JC; Touchon, RC, 1990) |
| "We report the occurrence of supraventricular tachycardia and hypotension in a 54-year-old woman after maintenance therapy with fluoxetine." | 3.68 | Drug-induced supraventricular tachycardia: a case report of fluoxetine. ( Gardner, SF; Munger, MA; Panacek, EA; Rutherford, WF, 1991) |
| "A four-month-old infant with myocarditis and supraventricular tachycardia was given intravenous verapamil (0." | 3.67 | An infant fatality following verapamil therapy for supraventricular tachycardia: cardiovascular collapse following intravenous verapamil. ( Berens, RJ; Garland, JS; Losek, JD; Wilson, AD, 1985) |
| "In a 67-year-old man with multiple myocardial infarctions in the past, the use of oral verapamil for control of angina pectoris was followed by the appearance of two previously undiagnosed abnormalities, namely, a dual-pathway AV node conduction pattern, and paroxysms of AV nodal reentrant tachycardia precipitated by premature ventricular beats (PVB)." | 3.67 | Verapamil-mediated atrioventricular nodal reentrant tachycardia and the uncovering of dual-pathway AV nodal conduction. ( Massumi, RA; Udhoji, VN, 1988) |
| "Intravenous verapamil is effective in the acute termination of supraventricular tachycardia but is also used for broad-complex tachycardia when the diagnosis is uncertain." | 3.67 | Misuse of intravenous verapamil in patients with ventricular tachycardia. ( Cobbe, SM; Rae, AP; Rankin, AC, 1987) |
| "The emergency treatment of supraventricular tachycardia (SVT) has, over the last two decades, changed from verapamil to adenosine primarily owing to documented hypotensive episodes occurring with rapid bolus infusions of the calcium channel blocker." | 2.74 | Slow infusion of calcium channel blockers compared with intravenous adenosine in the emergency treatment of supraventricular tachycardia. ( Anantharaman, V; Chan, YH; Lim, SH; Teo, WS, 2009) |
| "Left bundle branch block (LBBB)/superior axis morphology was most frequent morphology in adenosine group (55%)." | 2.74 | Electrophysiologic characteristics of wide QRS complexes during pharmacologic termination of sustained supraventricular tachycardias with verapamil and adenosine: observations from electrophysiologic study. ( Aliyev, F; Firatli, I; Incesoy, N; Oztürk, M; Türkoğlu, C, 2009) |
| " Adverse reactions to adenosine are common but are minor and brief." | 2.71 | [A randomized, multicenter trial to compare the safety and efficacy of adenosine versus verapamil for termination of paroxysmal supraventricular tachycardia]. ( Cheng, KA, 2003) |
| "Verapamil failures were treated with ATP and vice versa." | 2.68 | [Adenosine triphosphate in the treatment of supraventricular paroxysmal tachycardia: a comparison with verapamil]. ( Alises Moraleda, JM; Cortés Bermejo, S; García de Pedro, J; Gil Madre, J; Laín Teres, N; Lázaro Rodríguez, S; Sentenac Merchán, G; Sepúlveda Berrocal, MA, 1995) |
| "The incidence of conversion arrhythmias was similar in both treatment groups (adenosine 57%, verapamil 50%, p = NS)." | 2.67 | Adenosine versus verapamil in the treatment of supraventricular tachycardia: a randomized double-crossover trial. ( Hood, MA; Smith, WM, 1992) |
| "The chronic effect on ventricular extrasystoles of the degrees of severity mostly II-IV were investigated in the open experiment on 17 patients as well as on 3 patients with supraventricular dysrhythmias and on 30 patients with ventricular extrasystoles Lown III-IV in the single blind cross-over experiments to verapamil retard." | 2.67 | [Hemodynamic and clinical studies with Bonnecor--a new anti-arrhythmia drug]. ( Assmann, I; Kassel, P; von Knorre, G, 1990) |
| "Verapamil caused a lower ventricular rate, but only six (19%) of the patients (n = 31) converted to sinus rhythm within 4 h (p < 0." | 2.67 | The effect of magnesium versus verapamil on supraventricular arrhythmias. ( Birkeland, K; Gullestad, L; Høyer, MM; Kjekshus, J; Mølstad, P; Vanberg, P, 1993) |
| "verapamil (0." | 2.67 | Intraindividual comparison of diltiazem and verapamil on induction of paroxysmal supraventricular tachycardia. ( Aidonidis, I; Rizos, I; Seidl, KH; Senges, J; Stamou, S; Toutouzas, P, 1994) |
| "ATP is an effective treatment of supraventricular tachycardia when the atrioventricular (AV) node is part of the reentrant circuit." | 2.67 | Action of ATP on ventricular automaticity. ( Bachernegg, M; Decrinis, M; Domanowits, H; Kickenweiz, E; Laggner, AN; Stark, G; Stark, U; Sterz, F; Tritthart, HA, 1994) |
| "Adenosine was given to a total of 44 patients, 16 patients in the electrophysiology laboratory, and 28 patients in the emergency room for evaluation and termination of their tachycardia." | 2.66 | Adenosine: a clinical experience and comparison with verapamil for the termination of supraventricular tachycardias. ( Kirchhoffer, JB; Modesto, TA; Sellers, TD, 1987) |
| "Verapamil was given as a slow infusion over 10-30 min (rather than as a push) and each successfully cardioverted without incident." | 2.61 | Fascicular tachycardia in infancy and the use of verapamil: a case series and literature review. ( Binfield, A; Hornung, T; Kehr, J; Maxwell, F; Skinner, JR, 2019) |
| "Adenosine has a higher rate of minor adverse effects, and of overall adverse effects, whereas verapamil has a higher rate of causing hypotension." | 2.47 | The relative efficacy of adenosine versus verapamil for the treatment of stable paroxysmal supraventricular tachycardia in adults: a meta-analysis. ( Delaney, B; Kelly, AM; Loy, J, 2011) |
| "She had coronary atherosclerosis, liver cirrhosis and bradycardia-tachycardia syndrome." | 2.41 | Cardiogenic shock triggered by verapamil and atenolol: a case report of therapeutic experience with intravenous calcium. ( Hattori, K; Hirakawa, Y; Ichihashi, R; Kei, M; Matsubara, K; Saburi, Y; Sakurai, H; Tsukamoto, H; Yokouchi, K, 2000) |
| "Digoxin was given both to the mother and to the fetus." | 2.38 | [Hydrops fetalis in tachycardia: diagnostic and therapeutic procedures]. ( Arbenz, U; Baumann, H; Dudenhausen, J; Huch, A; Karrer, G; Vetter, K, 1990) |
| "In clinical arrhythmias, the main therapeutic role of calcium channel entry blockers is related to their effect on the sinus and atrioventricular (AV) node." | 2.38 | Use of calcium channel entry blockers in the treatment of cardiac arrhythmias. ( Akhtar, M; Jazayeri, M; Tchou, P, 1989) |
| "Adenosine and verapamil were similarly effective in terminating PSVT (74." | 1.32 | Heart rate is a predictor of success in the treatment of adults with symptomatic paroxysmal supraventricular tachycardia. ( Ballo, P; Bernabò, D; Faraguti, SA, 2004) |
| "The tachyarrhythmias were classified into atrial flutter (n = 8), supraventricular tachycardia (n = 18), arrhythmia absoluta (n = 5), parasystole (n = 1) and brady-tachyarrhythmia (n = 1)." | 1.32 | [Diagnosis and treatment of haemodynamically significant fetal tachycardia--in 33 cases]. ( Hajdú, J; Papp, Z; Pete, B, 2004) |
| "Adenosine and verapamil were equally successful in converting out-of-hospital SVT in patients with similar etiologies responsible for the SVT." | 1.29 | Treatment of out-of-hospital supraventricular tachycardia: adenosine vs verapamil. ( Brady, WJ; DeBehnke, DJ; Lindbeck, G; Wickman, LL, 1996) |
| "However, late recurrence of SVT has been recently described." | 1.29 | Probability of supraventricular tachycardia recurrence in pediatric patients. ( Chang, YC; Lin, JL; Lue, HC; Wang, JK; Wu, MH; Young, ML, 1994) |
| "Verapamil was used in one infant with AV node reentry tachycardia." | 1.29 | Efficacy and risks of medical therapy for supraventricular tachycardia in neonates and infants. ( Saul, JP; Walsh, EP; Weindling, SN, 1996) |
| "Esmolol or verapamil were administered by bolus and then infusion to incrementally slow the average ventricular rate." | 1.28 | Comparative effects of esmolol and verapamil in a model of a supraventricular tachydysrhythmia. ( Ivankovich, AD; Labarge, AM; McCarthy, RJ; Spiess, BD; Tuman, KJ; Wong, CA, 1990) |
| "Paroxysmal supraventricular tachycardia is the most common sustained cardiac arrhythmia in pregnant women." | 1.28 | Adenosine in the treatment of maternal paroxysmal supraventricular tachycardia. ( Koos, BJ; Mason, BA; Ricci-Goodman, J, 1992) |
| "Verapamil, however, was significantly more effective (18 of 24 attempts, 75%) than any of the other interventions either singly (P less than ." | 1.28 | Intravenous verapamil in the prehospital treatment of paroxysmal supraventricular tachycardia. ( Heller, MB; Menegazzi, JJ; O'Toole, KS; Paris, PM, 1990) |
| "Adenosine was successful in all, but verapamil failed to restore sinus rhythm at least once in seven of the 15 patients." | 1.28 | Verapamil or adenosine for the immediate treatment of supraventricular tachycardia. ( Cobbe, SM; Oldroyd, KG; Rae, AP; Rankin, AC, 1990) |
| "SVT complicated by hypotension has been considered a relative contraindication for the use of IV verapamil." | 1.28 | Supraventricular tachyarrhythmias and rate-related hypotension: cardiovascular effects and efficacy of intravenous verapamil. ( Haynes, BE; Haynes, KS; Niemann, JT, 1990) |
| "Verapamil was then administered to all 11 patients with the purpose of slowing the anterograde tachycardia wavefront before arrival of V2." | 1.28 | The excitable gap in atrioventricular nodal reentrant tachycardia. Characterization with ventricular extrastimuli and pharmacologic intervention. ( Lehmann, MH; Schuger, CD; Steinman, RT, 1989) |
| "Diltiazem was given to 10 patients; verapamil, to eight patients at doses of 0." | 1.28 | [Electrophysiologic effects of calcium channel blockers on supraventricular tachycardia in children]. ( Fujino, H; Fujiseki, Y; Shimada, M, 1989) |
| "Verapamil, a calcium channel-blocking drug, was administered IV at a dosage that ranged from 0." | 1.27 | Verapamil administration for acute termination of supraventricular tachycardia in dogs. ( Keene, B; Kittleson, M; Pion, P; Woodfield, J, 1988) |
| "Verapamil was introduced into a hospital-based urban/rural advanced life support (ALS) system for intravenous (IV) use in patients with symptomatic supraventricular tachyarrhythmias." | 1.27 | Prehospital use of intravenous verapamil. ( Eitel, DR; Pollack, M; Shaw, LC; Walton, SL, 1987) |
| "Verapamil was given to 16 consecutive patients with multifocal atrial tachycardia." | 1.27 | Intravenous verapamil for treatment of multifocal atrial tachycardia with and without calcium pretreatment. ( Anderson, B; Iber, C; Salerno, DM; Sharkey, PJ, 1987) |
| "A case of severe nonimmune hydrops fetalis caused by supraventricular tachycardia is presented." | 1.27 | Insufficient transplacental digoxin transfer in severe hydrops fetalis. ( Granat, M; Younis, JS, 1987) |
| "Verapamil appeared to increase pulmonary venous admixture." | 1.27 | Verapamil in multifocal atrial tachycardia. Hemodynamic and respiratory changes. ( Burnett, CR; Hazard, PB, 1987) |
| "Disopyramide was less effective than previously reported." | 1.27 | Effects of four antiarrhythmic drugs on the induction and termination of paroxysmal supraventricular tachycardia. ( Ishinaga, T; Komatsu, C; Tateishi, O; Tokuhisa, Y; Yoshimura, S, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 64 (34.97) | 18.7374 |
| 1990's | 80 (43.72) | 18.2507 |
| 2000's | 24 (13.11) | 29.6817 |
| 2010's | 13 (7.10) | 24.3611 |
| 2020's | 2 (1.09) | 2.80 |
| Authors | Studies |
|---|---|
| Yamabe, H | 2 |
| Soejima, T | 2 |
| Kajiyama, K | 2 |
| Fukami, Y | 2 |
| Haraguchi, K | 2 |
| Okonogi, T | 2 |
| Hirai, K | 2 |
| Fukuoka, R | 2 |
| Umeji, K | 2 |
| Orita, Y | 2 |
| Koga, H | 2 |
| Kawasaki, T | 2 |
| Alabed, S | 1 |
| Sabouni, A | 1 |
| Providencia, R | 1 |
| Atallah, E | 1 |
| Qintar, M | 1 |
| Chico, TJ | 1 |
| Kim, SJ | 1 |
| Gim, MS | 1 |
| Kehr, J | 1 |
| Binfield, A | 1 |
| Maxwell, F | 1 |
| Hornung, T | 1 |
| Skinner, JR | 1 |
| Nijjer, SS | 1 |
| Sohaib, SM | 1 |
| Whinnett, ZI | 1 |
| Lefroy, DC | 1 |
| Shaker, H | 1 |
| Jahanian, F | 1 |
| Fathi, M | 1 |
| Zare, M | 1 |
| Smith, G | 1 |
| McD Taylor, D | 1 |
| Morgans, A | 1 |
| Cameron, P | 1 |
| Bibas, L | 1 |
| Levi, M | 1 |
| Essebag, V | 1 |
| Volkov, VE | 1 |
| Babaev, FZ | 1 |
| Pshenitsin, AI | 1 |
| Zhezheva, FM | 1 |
| Mazur, NA | 1 |
| Lim, SH | 2 |
| Anantharaman, V | 2 |
| Teo, WS | 2 |
| Chan, YH | 1 |
| Medi, C | 1 |
| Kalman, JM | 1 |
| Freedman, SB | 1 |
| Türkoğlu, C | 1 |
| Oztürk, M | 1 |
| Aliyev, F | 1 |
| Firatli, I | 1 |
| Incesoy, N | 1 |
| Delaney, B | 1 |
| Loy, J | 1 |
| Kelly, AM | 1 |
| Kamberi, L | 1 |
| Citaku, H | 1 |
| Hoxha-Kamberi, T | 1 |
| De Rita, F | 1 |
| Barozzi, L | 1 |
| Franchi, G | 1 |
| Faggian, G | 1 |
| Mazzucco, A | 1 |
| Luciani, GB | 1 |
| Holdgate, A | 2 |
| Foo, A | 2 |
| Stengaard, C | 1 |
| Eiskjær, H | 1 |
| Jensen, HK | 1 |
| Garro, HA | 1 |
| Elizari, MV | 1 |
| Baranchuk, A | 1 |
| Femenía, F | 1 |
| Chiale, PA | 1 |
| Shiraishi, H | 1 |
| Ishibashi, K | 1 |
| Urao, N | 1 |
| Hyogo, M | 1 |
| Tsukamoto, M | 1 |
| Keira, N | 1 |
| Hirasaki, S | 1 |
| Seo, Y | 1 |
| Shirayama, T | 1 |
| Nakagawa, M | 2 |
| Kang, D | 1 |
| Verotta, D | 1 |
| Krecic-Shepard, ME | 1 |
| Modi, NB | 1 |
| Gupta, SK | 1 |
| Schwartz, JB | 1 |
| Hassan, SA | 1 |
| Oral, H | 1 |
| Scharf, C | 1 |
| Chugh, A | 1 |
| Pelosi, F | 1 |
| Knight, BP | 2 |
| Strickberger, SA | 2 |
| Morady, F | 3 |
| Luzza, F | 1 |
| Oreto, G | 1 |
| Cheng, KA | 1 |
| Ballo, P | 1 |
| Bernabò, D | 1 |
| Faraguti, SA | 1 |
| Steinbeck, G | 1 |
| Reithmann, C | 1 |
| Pete, B | 1 |
| Hajdú, J | 1 |
| Papp, Z | 1 |
| Hersi, A | 1 |
| Armstrong, PW | 1 |
| Choy, JB | 1 |
| Gulamhusein, S | 1 |
| Kavanagh, KM | 1 |
| Vranic, II | 1 |
| Matic, M | 1 |
| Perunicic, J | 1 |
| Simic, T | 1 |
| Soskic, L | 1 |
| Milic, N | 1 |
| Kao, SL | 1 |
| Ooi, S | 1 |
| Lee, KT | 1 |
| Chu, CS | 1 |
| Lin, TH | 1 |
| Yen, HW | 2 |
| Voon, WC | 2 |
| Sheu, SH | 2 |
| Lai, WT | 3 |
| Anugwom, C | 1 |
| Sulangi, S | 1 |
| Dachs, R | 1 |
| Fiszer, M | 1 |
| Kołaciński, Z | 1 |
| Rechciński, T | 1 |
| Vos, MA | 1 |
| Fazekas, T | 2 |
| Gorgels, AP | 1 |
| Leunissen, JD | 1 |
| Wellens, HJ | 1 |
| Stark, G | 1 |
| Domanowits, H | 1 |
| Sterz, F | 1 |
| Stark, U | 1 |
| Bachernegg, M | 1 |
| Kickenweiz, E | 1 |
| Decrinis, M | 1 |
| Laggner, AN | 1 |
| Tritthart, HA | 1 |
| Conti Giménez, LA | 1 |
| Zimmers, T | 2 |
| Hamer, AW | 2 |
| Strathmore, N | 1 |
| Vohra, JK | 1 |
| Hunt, VD | 1 |
| Belhassen, B | 1 |
| Viskin, S | 1 |
| Rizos, I | 1 |
| Seidl, KH | 1 |
| Aidonidis, I | 1 |
| Stamou, S | 1 |
| Senges, J | 1 |
| Toutouzas, P | 1 |
| Piovan, D | 1 |
| Padrini, R | 1 |
| Svalato Moreolo, G | 1 |
| Magnolfi, G | 1 |
| Milanesi, O | 1 |
| Zordan, R | 1 |
| Pellegrino, PA | 1 |
| Ferrari, M | 1 |
| Madsen, CD | 1 |
| Pointer, JE | 1 |
| Lynch, TG | 1 |
| Wu, MH | 1 |
| Chang, YC | 1 |
| Lin, JL | 1 |
| Young, ML | 1 |
| Wang, JK | 1 |
| Lue, HC | 1 |
| Gil Madre, J | 1 |
| Lázaro Rodríguez, S | 1 |
| Sentenac Merchán, G | 1 |
| Sepúlveda Berrocal, MA | 1 |
| Alises Moraleda, JM | 1 |
| Cortés Bermejo, S | 1 |
| García de Pedro, J | 1 |
| Laín Teres, N | 1 |
| Veress, G | 1 |
| Okamura, K | 2 |
| Jikuya, T | 2 |
| Mitsui, T | 2 |
| Hori, M | 2 |
| Haas, NA | 1 |
| Pufahl, C | 1 |
| König, SA | 1 |
| Gessler, P | 1 |
| Teufel, M | 1 |
| Roberge, RJ | 1 |
| Martin, TG | 1 |
| Hodgman, M | 1 |
| Benitez, JG | 1 |
| Brunswick, JE | 1 |
| Isomoto, S | 1 |
| Shimizu, A | 1 |
| Konoe, A | 1 |
| Tanigawa, M | 1 |
| Kaibara, M | 1 |
| Centurion, OA | 1 |
| Fukatani, M | 1 |
| Yano, K | 1 |
| Manz, M | 2 |
| Lüderitz, B | 1 |
| Peitz, TJ | 1 |
| Chang, JS | 1 |
| Hwang, YS | 1 |
| Chiu, HF | 1 |
| Tucker, KJ | 1 |
| Johnson, JA | 1 |
| Galli, F | 1 |
| Gullestad, L | 1 |
| Birkeland, K | 1 |
| Mølstad, P | 1 |
| Høyer, MM | 1 |
| Vanberg, P | 1 |
| Kjekshus, J | 1 |
| Weindling, SN | 1 |
| Saul, JP | 1 |
| Walsh, EP | 1 |
| Dorian, P | 1 |
| Naccarelli, GV | 1 |
| Coumel, P | 1 |
| Hohnloser, SH | 1 |
| Maser, MJ | 1 |
| O'Brien, JF | 1 |
| Tremml, GP | 1 |
| Falk, JL | 1 |
| Matteucci, C | 1 |
| Busi, G | 1 |
| Gausche, M | 1 |
| Brady, WJ | 1 |
| DeBehnke, DJ | 1 |
| Wickman, LL | 1 |
| Lindbeck, G | 1 |
| Hösl, P | 1 |
| Rust, M | 1 |
| Johannigmann, J | 1 |
| Schmidt, G | 1 |
| Crosson, JE | 1 |
| Hesslein, PS | 1 |
| Thilenius, OG | 1 |
| Dunnigan, A | 1 |
| Joshi, PP | 1 |
| Deshmukh, PK | 1 |
| Salkar, RG | 1 |
| Sandrock, J | 1 |
| Vester, EG | 1 |
| Yu, WC | 1 |
| Chen, SA | 1 |
| Lee, SH | 1 |
| Tai, CT | 1 |
| Feng, AN | 1 |
| Kuo, BI | 1 |
| Ding, YA | 1 |
| Chang, MS | 1 |
| Pina, MA | 1 |
| Ara, JR | 1 |
| Remírez, A | 1 |
| Castiella, J | 1 |
| Müller, U | 1 |
| Jochheim, R | 1 |
| Knaup, W | 1 |
| Tenholt, M | 1 |
| Gabbarini, F | 1 |
| Daoud, EG | 1 |
| Marcovitz, P | 1 |
| Goyal, R | 1 |
| Man, KC | 1 |
| Armstrong, WF | 1 |
| Trohman, RG | 1 |
| Sakurai, H | 1 |
| Kei, M | 1 |
| Matsubara, K | 1 |
| Yokouchi, K | 1 |
| Hattori, K | 1 |
| Ichihashi, R | 1 |
| Hirakawa, Y | 1 |
| Tsukamoto, H | 1 |
| Saburi, Y | 1 |
| Maiteh, M | 1 |
| Daoud, AS | 1 |
| Koshumbaeva, KM | 1 |
| Tulenov, MT | 1 |
| Belokopit, IN | 1 |
| Jespersen, CM | 1 |
| Vaage-Nilsen, M | 1 |
| Hansen, JF | 1 |
| Mason, BA | 1 |
| Ricci-Goodman, J | 1 |
| Koos, BJ | 1 |
| Jameson, SJ | 1 |
| Hargarten, SW | 1 |
| Hood, MA | 1 |
| Smith, WM | 1 |
| Kuhn, M | 1 |
| Schriger, DL | 1 |
| Orebaugh, SL | 1 |
| Handy, M | 1 |
| Mehta, AV | 1 |
| Chidambaram, B | 1 |
| O'Riordan, AC | 1 |
| Tai, YT | 2 |
| Fong, PC | 1 |
| Lau, CP | 2 |
| Chow, WH | 2 |
| Cheng, CH | 1 |
| Assmann, I | 1 |
| Kassel, P | 1 |
| von Knorre, G | 1 |
| Mariani, PJ | 2 |
| Caruso, AC | 1 |
| Yau, CC | 1 |
| Urbaszek, W | 1 |
| Traube, C | 1 |
| Marush, A | 1 |
| Plawes, S | 1 |
| Till, JA | 1 |
| Shinebourne, EA | 1 |
| Hirao, K | 1 |
| Okishige, K | 1 |
| Suzuki, F | 1 |
| Hiejima, K | 1 |
| Tuman, KJ | 1 |
| McCarthy, RJ | 1 |
| Wong, CA | 1 |
| Labarge, AM | 1 |
| Spiess, BD | 1 |
| Ivankovich, AD | 1 |
| Binder, LS | 1 |
| Boeche, R | 1 |
| Atkinson, D | 1 |
| Rankin, AC | 3 |
| McGovern, BA | 1 |
| Gardner, SF | 1 |
| Rutherford, WF | 1 |
| Munger, MA | 1 |
| Panacek, EA | 1 |
| Byerly, WG | 1 |
| Hartmann, A | 1 |
| Foster, DE | 1 |
| Tannenbaum, AK | 1 |
| Dolan, DL | 1 |
| Schwingshandl, J | 1 |
| Stein, JI | 1 |
| Häusler, M | 1 |
| Lu, Y | 1 |
| Varshavskiĭ, SIu | 1 |
| Medvedev, MM | 1 |
| Tsuchioka, Y | 1 |
| Nakagawa, H | 1 |
| Yamagata, T | 1 |
| Sakura, E | 1 |
| Hashimoto, M | 1 |
| Okamoto, M | 1 |
| Matsuura, H | 1 |
| Kajiyama, G | 1 |
| Dai, GZ | 1 |
| Zeng, B | 1 |
| Zhang, YL | 1 |
| Lu, YX | 1 |
| Finzi, A | 1 |
| Potenza, S | 1 |
| Guenzati, G | 1 |
| Liou, JY | 1 |
| Chen, CY | 1 |
| Karrer, G | 1 |
| Baumann, H | 1 |
| Vetter, K | 1 |
| Dudenhausen, J | 1 |
| Huch, A | 1 |
| Arbenz, U | 1 |
| Smetnev, AS | 1 |
| Islam, MN | 1 |
| Sokolov, SF | 1 |
| Golitsyn, SP | 1 |
| Bankuzov, VA | 1 |
| Malakhov, VI | 1 |
| DiMarco, JP | 1 |
| Miles, W | 1 |
| Akhtar, M | 2 |
| Milstein, S | 1 |
| Sharma, AD | 2 |
| Platia, E | 1 |
| McGovern, B | 1 |
| Scheinman, MM | 1 |
| Govier, WC | 1 |
| Bowles, HF | 1 |
| Thangathurai, D | 1 |
| Morgan, GE | 1 |
| Mikhail, M | 1 |
| Sreeram, N | 1 |
| Wren, C | 1 |
| Ramoska, EA | 1 |
| O'Toole, KS | 1 |
| Heller, MB | 1 |
| Menegazzi, JJ | 1 |
| Paris, PM | 1 |
| Barnett, JC | 1 |
| Touchon, RC | 1 |
| Atlee, JL | 2 |
| Bosnjak, ZJ | 1 |
| Yeager, TS | 1 |
| Rae, AP | 2 |
| Oldroyd, KG | 1 |
| Cobbe, SM | 2 |
| Mitchell, BK | 1 |
| Pinski, SL | 1 |
| Maloney, JD | 1 |
| Haynes, BE | 1 |
| Niemann, JT | 1 |
| Haynes, KS | 1 |
| Ilan, Y | 1 |
| Hillman, M | 1 |
| Oren, R | 1 |
| Fujiki, A | 3 |
| Yoshida, S | 3 |
| Mizumaki, K | 3 |
| Sasayama, S | 3 |
| Yeh, SJ | 1 |
| Lin, FC | 1 |
| Wu, DL | 1 |
| Garratt, C | 1 |
| Ward, D | 1 |
| Camm, AJ | 1 |
| Scher, DL | 1 |
| Arsura, EL | 1 |
| Singh, S | 1 |
| Goyal, L | 1 |
| Singhi, PD | 1 |
| Bidwai, PS | 1 |
| Walia, BN | 1 |
| Gembruch, U | 1 |
| Bald, R | 1 |
| Rüddel, H | 1 |
| Redel, DA | 1 |
| Schlebusch, H | 1 |
| Nitsch, J | 1 |
| Hansmann, M | 1 |
| Frisolone, JA | 1 |
| Petruk, J | 2 |
| Telichowski, C | 2 |
| Molenda, W | 2 |
| Banasiak, W | 2 |
| Aronow, WS | 1 |
| Lukoshiavichiute, AI | 2 |
| Gedrimene, DA | 2 |
| Tchou, P | 1 |
| Jazayeri, M | 1 |
| Mills, MS | 1 |
| Schuger, CD | 1 |
| Steinman, RT | 1 |
| Lehmann, MH | 1 |
| Millar, RN | 1 |
| Tani, M | 1 |
| Tsuji, H | 1 |
| Fujino, H | 1 |
| Fujiseki, Y | 1 |
| Shimada, M | 1 |
| Bayés de Luna, A | 1 |
| Oter, MC | 1 |
| Guindo, J | 1 |
| Kou, WH | 1 |
| Kadish, AH | 1 |
| Toivonen, LK | 1 |
| Kushner, JA | 1 |
| Schmaltz, S | 1 |
| Ornato, JP | 1 |
| Hallagan, LF | 1 |
| Reese, WA | 1 |
| Clark, RF | 1 |
| Tayal, VS | 1 |
| Garnett, AR | 1 |
| Gonzalez, ER | 1 |
| Belli, B | 1 |
| Michelucci, A | 1 |
| Monizzi, D | 1 |
| Barletta, G | 1 |
| Morace, G | 2 |
| Padeletti, L | 1 |
| Zatuchni, J | 1 |
| Kittleson, M | 1 |
| Keene, B | 1 |
| Pion, P | 1 |
| Woodfield, J | 1 |
| Prochaczek, F | 1 |
| Gałecka, J | 1 |
| Becker, A | 1 |
| Klein, GJ | 1 |
| Yee, R | 1 |
| Sellers, TD | 1 |
| Kirchhoffer, JB | 1 |
| Modesto, TA | 1 |
| Korcz, S | 1 |
| Nartowicz, E | 1 |
| Burduk, P | 1 |
| Ukleja-Adamowicz, M | 1 |
| Orzałkiewicz, Z | 1 |
| Kłobukowski, A | 1 |
| Silbert, MV | 1 |
| Ferguson, JE | 1 |
| Siukola, LV | 1 |
| Albright, GA | 1 |
| Massumi, RA | 1 |
| Udhoji, VN | 1 |
| Cardin, S | 1 |
| Hartshorn, JC | 1 |
| Deans, K | 1 |
| Huycke, EC | 1 |
| Sung, RJ | 1 |
| Walker, LA | 1 |
| MacMath, TL | 1 |
| Chipman, H | 1 |
| Bayne, E | 1 |
| Owen, J | 1 |
| Colvin, EV | 1 |
| Davis, RO | 1 |
| Friedli, B | 1 |
| Bolens, M | 1 |
| Shaw, LC | 1 |
| Eitel, DR | 1 |
| Walton, SL | 1 |
| Pollack, M | 1 |
| Nishimoto, T | 1 |
| Nakamura, H | 1 |
| Fujigaki, T | 1 |
| Hashiguchi, Y | 1 |
| Shibata, O | 1 |
| Haseba, S | 1 |
| Gotoh, Y | 1 |
| Kirk, CR | 1 |
| Gibbs, JL | 1 |
| Thomas, R | 1 |
| Radley-Smith, R | 1 |
| Qureshi, SA | 1 |
| Shigeta, O | 1 |
| Terada, Y | 1 |
| Maeta, H | 1 |
| Santinelli, V | 1 |
| De Paola, M | 1 |
| Smimmo, D | 1 |
| Turco, P | 1 |
| Condorelli, M | 1 |
| Saikawa, T | 1 |
| Inoue, K | 1 |
| Ohmura, I | 1 |
| Ito, S | 1 |
| Yonemochi, H | 1 |
| Ito, M | 1 |
| Ohashi, K | 1 |
| Ebihara, A | 1 |
| Tanasescu, DE | 1 |
| Marks, JW | 1 |
| Peter, T | 1 |
| Waxman, AD | 1 |
| Mandel, WJ | 1 |
| Ashby, D | 1 |
| Brickell, N | 1 |
| Kounis, NG | 1 |
| Mallioris, C | 1 |
| Milanov, S | 1 |
| Brankov, Kh | 1 |
| Kraeva, M | 1 |
| Koev, P | 1 |
| Salerno, DM | 1 |
| Anderson, B | 1 |
| Sharkey, PJ | 1 |
| Iber, C | 1 |
| Rao, PS | 1 |
| Najjar, HN | 1 |
| Younis, JS | 1 |
| Granat, M | 1 |
| Chan, KY | 1 |
| Yip, WC | 1 |
| Ng, MP | 1 |
| Tay, JS | 1 |
| Wong, HB | 1 |
| Tan, CL | 1 |
| Del Negro, AA | 1 |
| Fletcher, RD | 1 |
| Barbarash, RA | 1 |
| Bauman, JL | 1 |
| Lukazewski, AA | 1 |
| Srebro, JP | 1 |
| Rich, S | 1 |
| Rose, JS | 1 |
| Bhandari, A | 1 |
| Rahimtoola, SH | 1 |
| Wu, D | 1 |
| Walts, LF | 1 |
| Hazard, PB | 1 |
| Burnett, CR | 1 |
| Garson, A | 1 |
| Komatsu, C | 1 |
| Ishinaga, T | 1 |
| Tateishi, O | 1 |
| Tokuhisa, Y | 1 |
| Yoshimura, S | 1 |
| Castro, R | 1 |
| Perera, C | 1 |
| Doménech, E | 1 |
| Méndez, A | 1 |
| Ormazábal, C | 1 |
| Garland, JS | 1 |
| Berens, RJ | 1 |
| Losek, JD | 1 |
| Wilson, AD | 1 |
| Piñeiro, DJ | 1 |
| Romano, EA | 1 |
| Gallo, A | 1 |
| Vázquez Blanco, M | 1 |
| Suárez, LD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Simulation of Adenosine Push Methods for Treatment of SVT Using Agitated Saline Visualized by Ultrasound[NCT04051541] | 20 participants (Actual) | Interventional | 2019-05-06 | Completed | |||
| Treatment of Supraventricular Tachycardia in Patients With Non-cardiac Surgery by Dexmedetomidine During the Perioperative Period[NCT04284150] | 60 participants (Anticipated) | Interventional | 2020-02-26 | Not yet recruiting | |||
| A Randomised Controlled Trial of the Standard Versus a Simplified Adenosine Administration Method in the Treatment of Adult Patients With Supra- Ventricular Tachycardia (SVT)[NCT04392362] | Phase 3 | 30 participants (Actual) | Interventional | 2018-04-01 | Completed | ||
| Comparism Between Efficacy and Effectiveness Between Slow Infusion of Calcium Channel Blockers and Intravenous Bolus Adenosine in the Management of Supraventricular Tachycardia in the Emergency Department.[NCT00413712] | Phase 4 | 206 participants | Interventional | 1997-01-31 | Completed | ||
| Calcium Administration to Prevent Hypotension Caused by Diltiazem Administration in the Treatment of Atrial Fibrillation With Rapid Ventricular Response[NCT05691959] | Phase 2 | 378 participants (Anticipated) | Interventional | 2023-01-26 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The primary outcome is the rhythm of conversion to a sinus rhythm less than 140 beat per minute. (NCT04392362)
Timeframe: 10 seconds
| Intervention | participants (Number) |
|---|---|
| Intervention Group | 13 |
| Control Group | 4 |
24 reviews available for verapamil and Tachycardia, Supraventricular
| Article | Year |
|---|---|
Adenosine versus intravenous calcium channel antagonists for supraventricular tachycardia.
Topics: Adenosine; Adult; Anti-Arrhythmia Agents; Calcium Channel Blockers; Emergency Service, Hospital; Hum | 2017 |
Adenosine versus intravenous calcium channel antagonists for supraventricular tachycardia.
Topics: Adenosine; Adult; Anti-Arrhythmia Agents; Calcium Channel Blockers; Emergency Service, Hospital; Hum | 2017 |
Adenosine versus intravenous calcium channel antagonists for supraventricular tachycardia.
Topics: Adenosine; Adult; Anti-Arrhythmia Agents; Calcium Channel Blockers; Emergency Service, Hospital; Hum | 2017 |
Adenosine versus intravenous calcium channel antagonists for supraventricular tachycardia.
Topics: Adenosine; Adult; Anti-Arrhythmia Agents; Calcium Channel Blockers; Emergency Service, Hospital; Hum | 2017 |
Fascicular tachycardia in infancy and the use of verapamil: a case series and literature review.
Topics: Anti-Arrhythmia Agents; Child Health Services; Diagnosis, Differential; Drug Administration Schedule | 2019 |
Management of supraventricular tachycardias.
Topics: Adenosine; Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Calcium Channel Blockers; Comorbidit | 2014 |
Diagnosis and management of supraventricular tachycardias.
Topics: Adenosine; Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Calcium Channel Blockers; Catheter A | 2016 |
[Clinical application of verapamil in patients with supraventricular cardiac rhythm disturbances and arterial hypertension].
Topics: Blood Pressure; Calcium Channel Blockers; Heart Rate; Humans; Hypertension; Tachycardia, Supraventri | 2008 |
Supraventricular tachycardia.
Topics: Adenosine; Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Cardiovascular Agents; Diltiazem; El | 2009 |
The relative efficacy of adenosine versus verapamil for the treatment of stable paroxysmal supraventricular tachycardia in adults: a meta-analysis.
Topics: Adenosine; Adult; Anti-Arrhythmia Agents; Confidence Intervals; Humans; Tachycardia, Supraventricula | 2011 |
WITHDRAWN: Adenosine versus intravenous calcium channel antagonists for the treatment of supraventricular tachycardia in adults.
Topics: Adenosine; Adult; Anti-Arrhythmia Agents; Calcium Channel Blockers; Humans; Randomized Controlled Tr | 2012 |
Adenosine versus intravenous calcium channel antagonists for the treatment of supraventricular tachycardia in adults.
Topics: Adenosine; Adult; Calcium Channel Blockers; Humans; Randomized Controlled Trials as Topic; Tachycard | 2006 |
Adenosine vs. calcium channel blockers for supraventricular tachycardia.
Topics: Adenosine; Anti-Arrhythmia Agents; Calcium Channel Blockers; Half-Life; Humans; Societies, Medical; | 2007 |
What is the drug of choice for the acute termination of paroxysmal supraventricular tachycardia: verapamil, adenosine triphosphate, or adenosine?
Topics: Adenosine; Adenosine Triphosphate; Adult; Arrhythmias, Cardiac; Child; Clinical Trials as Topic; Dru | 1993 |
Supraventricular tachycardia and pre-excitation syndromes: pharmacological therapy.
Topics: Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Disopyramide; Fle | 1993 |
[Clinico-electrophysiologic effects of magnesium, especially in supraventricular tachycardia].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Dose-Response Relationship, Drug; Electrocardiography; Female; | 1997 |
Supraventricular tachycardia: implications for the intensivist.
Topics: Adenosine; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electrocardiogra | 2000 |
Cardiogenic shock triggered by verapamil and atenolol: a case report of therapeutic experience with intravenous calcium.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Atrial Fibrillation; Bradycardia; Calcium Channel Block | 2000 |
Myoclonic seizure following intravenous verapamil injection: case report and review of the literature.
Topics: Anti-Arrhythmia Agents; Female; Humans; Infant; Injections, Intravenous; Myoclonus; Tachycardia, Sup | 2001 |
Supraventricular tachycardia. Changes in management.
Topics: Adenosine; Diagnosis, Differential; Education, Medical, Continuing; Electrocardiography; Electrocoag | 1991 |
Supraventricular tachycardia: diagnosis and current acute management.
Topics: Adenosine; Electric Countershock; Electrocardiography; Flecainide; Humans; Infant; Infant, Newborn; | 1991 |
[Hydrops fetalis in tachycardia: diagnostic and therapeutic procedures].
Topics: Adult; Digoxin; Drug Therapy, Combination; Female; Heart Failure; Heart Rate, Fetal; Humans; Hydrops | 1990 |
Multifocal atrial tachycardia: mechanisms, clinical correlates, and treatment.
Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Female; Heart Conduction System; Humans; | 1989 |
Management of supraventricular tachyarrhythmias.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Bradycardia; Huma | 1989 |
[Anti-arrhythmia therapy with Ca++-antagonists].
Topics: Arrhythmias, Cardiac; Calcium Channel Blockers; Humans; Tachycardia, Paroxysmal; Tachycardia, Suprav | 1989 |
Use of calcium channel entry blockers in the treatment of cardiac arrhythmias.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrioventricular Node; Calcium Channel Blockers; Dilti | 1989 |
An approach to therapy for paroxysmal supraventricular tachycardia.
Topics: Cardiac Pacing, Artificial; Electric Countershock; Heart Conduction System; Humans; Tachycardia, Par | 1988 |
32 trials available for verapamil and Tachycardia, Supraventricular
| Article | Year |
|---|---|
Oral verapamil in paroxysmal supraventricular tachycardia recurrence control: a randomized clinical trial.
Topics: Administration, Oral; Adult; Aged; Female; Humans; Male; Middle Aged; Prospective Studies; Recurrenc | 2015 |
Slow infusion of calcium channel blockers compared with intravenous adenosine in the emergency treatment of supraventricular tachycardia.
Topics: Adenosine; Adult; Anti-Arrhythmia Agents; Blood Pressure; Calcium Channel Blockers; Diltiazem; Dose- | 2009 |
Electrophysiologic characteristics of wide QRS complexes during pharmacologic termination of sustained supraventricular tachycardias with verapamil and adenosine: observations from electrophysiologic study.
Topics: Adenosine; Anti-Arrhythmia Agents; Bundle-Branch Block; Electrocardiography; Electrophysiology; Fema | 2009 |
Rate-dependent effect of verapamil on atrial refractoriness.
Topics: Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium Channels; Electrophysiologic Techniques, | 2003 |
[A randomized, multicenter trial to compare the safety and efficacy of adenosine versus verapamil for termination of paroxysmal supraventricular tachycardia].
Topics: Adenosine; Adult; Aged; Female; Humans; Male; Middle Aged; Tachycardia, Paroxysmal; Tachycardia, Sup | 2003 |
Adenosine cardioprotection study in clinical setting of paroxysmal supraventricular tachycardia.
Topics: 6-Ketoprostaglandin F1 alpha; Adenosine; Adult; Cardiotonic Agents; Female; Humans; Male; Middle Age | 2006 |
Action of ATP on ventricular automaticity.
Topics: Adenosine Triphosphate; Adrenergic beta-Antagonists; Ajmaline; Animals; Anti-Arrhythmia Agents; Aust | 1994 |
Oral flecainide, sotalol, and verapamil for the termination of paroxysmal supraventricular tachycardia.
Topics: Administration, Oral; Adult; Cardiac Pacing, Artificial; Female; Flecainide; Humans; Male; Middle Ag | 1993 |
Intraindividual comparison of diltiazem and verapamil on induction of paroxysmal supraventricular tachycardia.
Topics: Adult; Aged; Diltiazem; Female; Humans; Male; Middle Aged; Tachycardia, Atrioventricular Nodal Reent | 1994 |
Verapamil and norverapamil plasma levels in infants and children during chronic oral treatment.
Topics: Administration, Oral; Adolescent; Aging; Cardiomyopathy, Dilated; Child; Child, Preschool; Female; H | 1995 |
[Adenosine triphosphate in the treatment of supraventricular paroxysmal tachycardia: a comparison with verapamil].
Topics: Adenosine Triphosphate; Adult; Aged; Contraindications; Drug Evaluation; Female; Humans; Infusions, | 1995 |
The treatment of intractable supraventricular tachycardia after open heart surgery by a continuous infusion of verapamil and ventricular pacing.
Topics: Adult; Cardiac Pacing, Artificial; Cardiac Surgical Procedures; Female; Hemodynamics; Humans; Infusi | 1994 |
The effect of magnesium versus verapamil on supraventricular arrhythmias.
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Female; Heart Rate; Humans; Infusions, In | 1993 |
A randomized comparison of flecainide versus verapamil in paroxysmal supraventricular tachycardia. The Flecainide Multicenter Investigators Group.
Topics: Administration, Oral; Adult; Aged; Anti-Arrhythmia Agents; Electrocardiography; Female; Flecainide; | 1996 |
Efficacy of intravenous magnesium sulphate in supraventricular tachyarrhythmias.
Topics: Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Blood Pressure; Female; Heart Ra | 1995 |
[Clinico-electrophysiologic effects of magnesium, especially in supraventricular tachycardia].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Dose-Response Relationship, Drug; Electrocardiography; Female; | 1997 |
Tachycardia-induced change of atrial refractory period in humans: rate dependency and effects of antiarrhythmic drugs.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Electroph | 1998 |
Slow-infusion of calcium channel blockers in the emergency management of supraventricular tachycardia.
Topics: Calcium Channel Blockers; Diltiazem; Electrocardiography; Emergency Treatment; Female; Humans; Infus | 2002 |
[Efficiency of antiarrhythmic drugs of class 1C and isoptin in paroxysmal supraventricular tachycardia].
Topics: Aconitine; Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Cross-Over Studies; Female; Humans; Male | 2002 |
The significance of myocardial ischaemia and verapamil treatment on the prevalence of supraventricular tachyarrhythmias in patients recovering from acute myocardial infarction. Danish Study Group on Verapamil in Myocardial Infarction.
Topics: Double-Blind Method; Electrocardiography, Ambulatory; Exercise Test; Female; Humans; Male; Middle Ag | 1992 |
Adenosine versus verapamil in the treatment of supraventricular tachycardia: a randomized double-crossover trial.
Topics: Adenosine; Adult; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Female; Humans; Male; Midd | 1992 |
[Hemodynamic and clinical studies with Bonnecor--a new anti-arrhythmia drug].
Topics: Administration, Oral; Adult; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Cardiomyopathy, H | 1990 |
Intravenous tetrandrine in terminating acute episodes of paroxysmal supraventricular tachycardia.
Topics: Adolescent; Adult; Aged; Alkaloids; Anti-Arrhythmia Agents; Benzylisoquinolines; Electrocardiography | 1990 |
[Comparative study of the effects of verapamil, ethmozin and ethacizine on provoked attacks of atrioventricular nodal reciprocal tachycardia].
Topics: Adult; Atrioventricular Node; Cardiac Pacing, Artificial; Clinical Trials as Topic; Female; Heart Co | 1990 |
Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials. The Adenosine for PSVT Study Group.
Topics: Acute Disease; Adenosine; Adult; Aged; Clinical Protocols; Confounding Factors, Epidemiologic; Dose- | 1990 |
[Anti-arrhythmia effectiveness of phosphobion and finoptin in the treatment of atrioventricular retrograde paroxysmal tachycardia].
Topics: Adenosine Triphosphate; Adolescent; Adult; Aged; Clinical Trials as Topic; Female; Humans; Male; Mid | 1989 |
[Comparative effectiveness of finoptin and phosphobion in treating attacks of supraventricular tachycardia].
Topics: Adenosine Triphosphate; Adolescent; Adult; Aged; Atrioventricular Node; Clinical Trials as Topic; El | 1989 |
Interatrial conduction block with retrograde activation of the left atrium and paroxysmal supraventricular tachyarrhythmias: influence of preventive antiarrhythmic treatment.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electrocardiography; | 1989 |
Adenosine: a clinical experience and comparison with verapamil for the termination of supraventricular tachycardias.
Topics: Adenosine; Atrioventricular Node; Clinical Trials as Topic; Emergencies; Humans; Tachycardia, Suprav | 1987 |
[Effect of verapamil on the electrophysiological properties of the atrioventricular node in patients with atrioventricular nodal tachycardia].
Topics: Adult; Atrioventricular Node; Clinical Trials as Topic; Female; Heart Conduction System; Humans; Mal | 1987 |
[Verapamil in the treatment of paroxysmal supraventricular arrhythmia].
Topics: Adolescent; Adult; Aged; Ajmaline; Child; Child, Preschool; Clinical Trials as Topic; Female; Humans | 1987 |
Effective termination of reentrant supraventricular tachycardia by single dose oral combination therapy with pindolol and verapamil.
Topics: Adult; Aged; Cardiac Pacing, Artificial; Drug Combinations; Electrophysiology; Female; Heart Conduct | 1986 |
128 other studies available for verapamil and Tachycardia, Supraventricular
| Article | Year |
|---|---|
Efficacy of catheter ablation from the noncoronary aortic cusp of verapamil-sensitive atrial tachycardia arising near the atrioventricular node.
Topics: Atrioventricular Node; Catheter Ablation; Electrocardiography; Humans; Tachycardia; Tachycardia, Sup | 2022 |
Comparison of the catheter ablation outcome in patients between targeting the entrance and exit of the reentry circuit in verapamil-sensitive atrial tachycardia originating from the atrioventricular-node vicinity.
Topics: Atrioventricular Node; Catheter Ablation; Electrocardiography; Humans; Tachycardia; Tachycardia, Atr | 2021 |
Clozapine-related Paroxysmal Supraventricular Tachycardia: a Case Report.
Topics: Anti-Arrhythmia Agents; Antipsychotic Agents; Clozapine; Female; Humans; Middle Aged; Recurrence; Ta | 2018 |
Measuring the effectiveness of a revised clinical practice guideline for the pre-hospital management of supraventricular tachycardia.
Topics: Adenosine; Adult; Aged; Anti-Arrhythmia Agents; Disease Management; Electric Countershock; Emergency | 2015 |
Supraventricular tachycardia in pregnancy.
Topics: Adenosine; Adult; Anti-Arrhythmia Agents; Female; Humans; Pregnancy; Pregnancy Complications, Cardio | 2010 |
Rescue extracorporeal life support for acute verapamil and propranolol toxicity in a neonate.
Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Extracorporeal Membrane Oxygenation; Female; | 2011 |
[Fulminant acute heart failure following intravenous bolus administration of verapamil in a patient with supraventricular tachycardia].
Topics: Administration, Intravenous; Adult; Calcium Channel Blockers; Electrocardiography; Heart Failure; Hu | 2013 |
A reappraisal on lidocaine-sensitive repetitive, uniform atrial tachycardia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Catheter Ablation; Combined Moda | 2013 |
Two cases of polymorphic ventricular tachycardia induced by the administration of verapamil against paroxysmal supraventricular tachycardia.
Topics: Anti-Arrhythmia Agents; Catheter Ablation; Electrocardiography; Electrophysiologic Techniques, Cardi | 2002 |
Population analyses of sustained-release verapamil in patients: effects of sex, race, and smoking.
Topics: Administration, Oral; Adult; Aged; Anti-Arrhythmia Agents; Antihypertensive Agents; Coronary Disease | 2003 |
Verapamil-induced electrical and cycle length alternans during supraventricular tachycardia: what is the mechanism?
Topics: Anti-Arrhythmia Agents; Electrocardiography; Humans; Male; Middle Aged; Tachycardia, Supraventricula | 2003 |
Heart rate is a predictor of success in the treatment of adults with symptomatic paroxysmal supraventricular tachycardia.
Topics: Adenosine; Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Carotid Sinus; Female; Heart Rate; Human | 2004 |
Paroxysmal supraventricular tachycardia: preferential use of either adenosine or verapamil is dependent on the rate of tachycardia.
Topics: Adenosine; Anti-Arrhythmia Agents; Humans; Tachycardia, Supraventricular; Verapamil | 2004 |
[Diagnosis and treatment of haemodynamically significant fetal tachycardia--in 33 cases].
Topics: Amiodarone; Anti-Arrhythmia Agents; Digoxin; Electric Countershock; Female; Fetal Diseases; Follow-U | 2004 |
Pulmonary edema post-cardioversion: a potential calcium signalling problem.
Topics: Adenosine; Anti-Arrhythmia Agents; Calcium Signaling; Drug Therapy, Combination; Echocardiography, T | 2006 |
A case of a borderline-broad complex tachycardia.
Topics: Adenosine; Anti-Arrhythmia Agents; Atrial Fibrillation; Bundle-Branch Block; Carotid Sinus; Diagnosi | 2006 |
Effect of sodium and calcium channel blockers on short-term cardiac memory in humans.
Topics: Anti-Arrhythmia Agents; Calcium Channel Blockers; Cardiac Pacing, Artificial; Catheter Ablation; Com | 2008 |
[The application of 4-aminopyridine in calcium channel inhibitors acute poisoning].
Topics: 4-Aminopyridine; Acute Disease; Adrenergic beta-Antagonists; Adult; Antidotes; Antihypertensive Agen | 2007 |
Action of MgSO4 differs from moricizine and verapamil on ouabain-induced ventricular tachycardia in normomagnesemic conscious dogs.
Topics: Action Potentials; Animals; Dogs; Electric Stimulation; Female; Heart Block; Magnesium Deficiency; M | 1994 |
[Adenosine triphosphate in the treatment of supraventricular paroxysmal tachycardia: comparison with verapamil].
Topics: Adenosine Triphosphate; Electrocardiography; Humans; Tachycardia, Paroxysmal; Tachycardia, Supravent | 1995 |
Cases in electrocardiography.
Topics: Accelerated Idioventricular Rhythm; Aged; Electrocardiography; Female; Heart Arrest; Heart Conductio | 1995 |
A comparison of adenosine and verapamil for the treatment of supraventricular tachycardia in the prehospital setting.
Topics: Adenosine; Adult; Aged; Aged, 80 and over; Diagnostic Errors; Electrocardiography; Emergency Medical | 1995 |
A comparison of adenosine and verapamil for the treatment of supraventricular tachycardia in the prehospital setting.
Topics: Adenosine; Adult; Aged; Aged, 80 and over; Diagnostic Errors; Electrocardiography; Emergency Medical | 1995 |
A comparison of adenosine and verapamil for the treatment of supraventricular tachycardia in the prehospital setting.
Topics: Adenosine; Adult; Aged; Aged, 80 and over; Diagnostic Errors; Electrocardiography; Emergency Medical | 1995 |
A comparison of adenosine and verapamil for the treatment of supraventricular tachycardia in the prehospital setting.
Topics: Adenosine; Adult; Aged; Aged, 80 and over; Diagnostic Errors; Electrocardiography; Emergency Medical | 1995 |
Probability of supraventricular tachycardia recurrence in pediatric patients.
Topics: Actuarial Analysis; Age Factors; Child; Child, Preschool; Electrocardiography; Electrophysiology; Fe | 1994 |
[AV reciprocating tachycardia with intermittent bundle branch block in latent Wolff-Parkinson-White syndrome].
Topics: Adrenergic beta-Antagonists; Adult; Bundle-Branch Block; Digitalis Glycosides; Electrocardiography; | 1994 |
[Adenosine triphosphate for supraventricular tachycardia in newborns and suckling infants].
Topics: Adenosine Triphosphate; Digoxin; Drug Therapy, Combination; Echocardiography; Electrocardiography; E | 1994 |
Supraventricular tachyarrhythmia associated with baclofen overdose.
Topics: Adenosine; Adult; Baclofen; Drug Overdose; Electrocardiography; Humans; Intubation, Intratracheal; M | 1994 |
Effects of intravenous verapamil on atrial vulnerability.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Atrial Fibrillation; Electrocardiography; Female; Heart | 1994 |
Intravenous diltiazem hydrochloride rather than verapamil for resistant paroxysmal supraventricular tachycardia.
Topics: Diltiazem; Drug Tolerance; Humans; Hypotension; Injections, Intravenous; Tachycardia, Paroxysmal; Ta | 1993 |
Comparison of the electrophysiologic effects of oral sustained-release and intravenous verapamil in patients with paroxysmal supraventricular tachycardia.
Topics: Administration, Oral; Cardiac Pacing, Artificial; Delayed-Action Preparations; Electrocardiography; | 1993 |
Adenosine AV block.
Topics: Adenosine; Atrioventricular Node; Humans; Tachycardia, Supraventricular; Verapamil | 1993 |
Efficacy and risks of medical therapy for supraventricular tachycardia in neonates and infants.
Topics: Anti-Arrhythmia Agents; Catheter Ablation; Digoxin; Electrocardiography; Esophagus; Female; Follow-U | 1996 |
Intravenous calcium chloride in the conversion of paroxysmal supraventricular tachycardia to normal sinus rhythm.
Topics: Adult; Anti-Arrhythmia Agents; Calcium Chloride; Drug Therapy, Combination; Electrocardiography; Fem | 1996 |
[Role of a "bystander" concealed accessory pathway in the response to verapamil and flecainide treatment in a patient with nodal reentry tachycardia].
Topics: Anti-Arrhythmia Agents; Child; Echocardiography; Electrocardiography, Ambulatory; Flecainide; Heart | 1996 |
To treat or not to treat (out-of-hospital) paroxysmal supraventricular tachycardia, that is the question.
Topics: Adenosine; Ambulatory Care; Anti-Arrhythmia Agents; Electrocardiography; Humans; Tachycardia, Suprav | 1996 |
Treatment of out-of-hospital supraventricular tachycardia: adenosine vs verapamil.
Topics: Adenosine; Adult; Aged; Allied Health Personnel; Ambulatory Care; Anti-Arrhythmia Agents; Combined M | 1996 |
[Paroxysmal supraventricular tachycardia in pregnancy. Value of adenosine and other anti-arrhythmia agents].
Topics: Adenosine; Adult; Anti-Arrhythmia Agents; Electrocardiography; Female; Heart Rate; Humans; Infant, N | 1996 |
AV node reentry tachycardia in infants.
Topics: Adenosine; Diagnosis, Differential; Electrocardiography; Female; Follow-Up Studies; Humans; Infant; | 1995 |
A quick guide to converting rapid rhythms. When seconds count, use this chart to guide treatment choices.
Topics: Adenosine; Anti-Arrhythmia Agents; Calcium Channel Blockers; Diltiazem; Humans; Tachycardia, Paroxys | 1997 |
Verapamil and acute dystonia.
Topics: Adult; Anti-Arrhythmia Agents; Diazepam; Dystonia; Female; Humans; Injections, Intravenous; Muscle R | 1998 |
[Implantable event recorder: a new aid for the diagnosis of arrhythmogenic syncope].
Topics: Anti-Arrhythmia Agents; Atrial Premature Complexes; Digitalis Glycosides; Drug Eruptions; Electrocar | 1998 |
A 61-year-old man with Holmes' heart.
Topics: Amlodipine; Anti-Arrhythmia Agents; Antihypertensive Agents; Cardiac Output, Low; Heart Defects, Con | 1999 |
Short-term effect of atrial fibrillation on atrial contractile function in humans.
Topics: Adult; Atrial Fibrillation; Atrial Function, Left; Atrial Function, Right; Calcium Channel Blockers; | 1999 |
Adenosine in the treatment of maternal paroxysmal supraventricular tachycardia.
Topics: Adenosine; Adult; Female; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outc | 1992 |
Calcium pretreatment to prevent verapamil-induced hypotension in patients with SVT.
Topics: Calcium; Humans; Hypotension; Premedication; Tachycardia, Supraventricular; Verapamil | 1992 |
Low-dose calcium pretreatment to prevent verapamil-induced hypotension.
Topics: Blood Pressure; Calcium; Humans; Hypotension; Incidence; Middle Aged; Premedication; Retrospective S | 1992 |
Intravenous adenosine therapy accelerating rate of paroxysmal supraventricular tachycardia.
Topics: Adenosine; Adult; Electrocardiography; Female; Heart; Humans; Injections, Intravenous; Middle Aged; | 1992 |
Verapamil-induced gingival hyperplasia in children.
Topics: Adolescent; Child; Female; Gingival Hyperplasia; Humans; Tachycardia, Supraventricular; Time Factors | 1992 |
Reentrant fascicular tachycardia with cycle length alternans: insights into the tachycardia mechanism and origin.
Topics: Bundle of His; Bundle-Branch Block; Cardiac Pacing, Artificial; Diltiazem; Electrocardiography; Elec | 1990 |
Pharmacotherapy of pregnancy--related SVT.
Topics: Female; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Tachycardia, Paroxysmal; Tachyca | 1992 |
Verapamil and ventricular tachycardias.
Topics: Female; Humans; In Vitro Techniques; Injections, Intravenous; Male; Middle Aged; Tachycardia; Tachyc | 1991 |
[Early therapy of absolute tachyarrhythmia].
Topics: Anti-Arrhythmia Agents; Anticoagulants; Humans; Tachycardia, Supraventricular; Ventricular Fibrillat | 1991 |
An approach to the diagnosis of wide QRS tachycardias.
Topics: Diagnosis, Differential; Electrocardiography; Heart Rate; Hemodynamics; Humans; Hypotension; Tachyca | 1991 |
Combination therapy with aprindine and verapamil for paroxysmal supraventricular tachycardia as assessed by transesophageal atrial pacing.
Topics: Administration, Oral; Adult; Aged; Aprindine; Drug Administration Schedule; Drug Therapy, Combinatio | 1991 |
Comparative effects of esmolol and verapamil in a model of a supraventricular tachydysrhythmia.
Topics: Adrenergic beta-Antagonists; Animals; Coronary Circulation; Depression, Chemical; Dogs; Female; Hemo | 1990 |
Evaluation and management of supraventricular tachycardia in children.
Topics: Anemia; Dehydration; Dopamine; Electric Countershock; Fluid Therapy; Heart Defects, Congenital; Huma | 1991 |
Adenosine or verapamil for the acute treatment of supraventricular tachycardia?
Topics: Adenosine; Emergencies; Humans; Tachycardia, Supraventricular; Verapamil | 1991 |
Drug-induced supraventricular tachycardia: a case report of fluoxetine.
Topics: Electrocardiography; Female; Fluoxetine; Humans; Hypotension; Middle Aged; Tachycardia, Supraventric | 1991 |
Verapamil in the treatment of maternal paroxysmal supraventricular tachycardia.
Topics: Adult; Electrocardiography; Female; Heart Rate, Fetal; Humans; Pregnancy; Pregnancy Complications, C | 1991 |
Intravenous calcium before verapamil to prevent hypotension.
Topics: Calcium; Humans; Hypotension; Infusions, Intravenous; Tachycardia, Supraventricular; Verapamil | 1991 |
[Successful intrauterine treatment of a supraventricular tachycardia-induced hydrops fetalis with digoxin and verapamil].
Topics: Digoxin; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Fetal | 1991 |
[Clinical observation on the termination of paroxysmal supraventricular tachycardia by tetrandrine].
Topics: Adult; Alkaloids; Anti-Arrhythmia Agents; Benzylisoquinolines; Female; Humans; Male; Middle Aged; Ta | 1990 |
[Control of the paroxysms of supraventricular tachycardia at the pre-hospital stage: finoptin or adenosine triphosphate?].
Topics: Adenosine Triphosphate; Adolescent; Adult; Aged; Child; First Aid; Heart Rate; Humans; Infusions, In | 1990 |
[Effects of verapamil and disopyramide phosphate on the termination, reinduction and long-term prevention of paroxysmal supraventricular tachycardia].
Topics: Administration, Oral; Adult; Disopyramide; Drug Evaluation; Electrophysiology; Female; Humans; Injec | 1990 |
[His bundle block 2:1 during paroxysmal supraventricular tachycardia involving an occult accessory atrio-His pathway].
Topics: Bundle of His; Electrocardiography; Female; Flecainide; Heart Block; Heart Conduction System; Humans | 1990 |
[Atrial tachycardia with block in congenital atrial septal defect. A case report].
Topics: Drug Therapy, Combination; Heart Block; Heart Septal Defects, Atrial; Humans; Male; Middle Aged; Qui | 1990 |
Management of supraventricular tachycardia in septic patients.
Topics: Drug Therapy, Combination; Humans; Phenylephrine; Shock, Septic; Tachycardia, Supraventricular; Vera | 1990 |
Supraventricular tachycardia in infants: response to initial treatment.
Topics: Adenosine; Digoxin; Electric Countershock; Humans; Hypothermia, Induced; Infant; Infant, Newborn; Pr | 1990 |
Cases in electrocardiography.
Topics: Aged; Aged, 80 and over; Child; Child, Preschool; Electrocardiography; Heart Block; Humans; Male; Pa | 1990 |
Intravenous verapamil in the prehospital treatment of paroxysmal supraventricular tachycardia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Clinical Protocols; Cryotherapy; Emergency Medica | 1990 |
Short-term control of supraventricular tachycardia with verapamil infusion and calcium pretreatment.
Topics: Aged; Atrial Fibrillation; Atrial Flutter; Blood Pressure; Calcium; Female; Heart Rate; Humans; Infu | 1990 |
Effects of diltiazem, verapamil, and inhalation anesthetics on electrophysiologic properties affecting reentrant supraventricular tachycardia in chronically instrumented dogs.
Topics: Animals; Diltiazem; Dogs; Drug Interactions; Electrophysiology; Enflurane; Female; Halothane; Heart; | 1990 |
Verapamil or adenosine for the immediate treatment of supraventricular tachycardia.
Topics: Adenosine; Adolescent; Adult; Aged; Blood Pressure; Drug Therapy, Combination; Electrocardiography; | 1990 |
The littlest cardiologist.
Topics: Adult; Electrocardiography; Female; Fetus; Humans; Pregnancy; Pregnancy Complications, Cardiovascula | 1990 |
Adenosine: a new drug for acute termination of supraventricular tachycardia.
Topics: Adenosine; Diagnosis, Differential; Drug Administration Schedule; Heart Ventricles; Humans; Infusion | 1990 |
Supraventricular tachyarrhythmias and rate-related hypotension: cardiovascular effects and efficacy of intravenous verapamil.
Topics: Adult; Aged; Aged, 80 and over; Blood Pressure; Female; Heart Rate; Humans; Hypotension; Injections, | 1990 |
Intravenous verapamil for tachyarrhythmia in Duchenne's muscular dystrophy.
Topics: Adolescent; Heart Failure; Heart Rate; Humans; Infusions, Intravenous; Male; Muscular Dystrophies; T | 1990 |
Fast-slow type of atrioventricular nodal reentrant tachycardia: horizontal dissociation of the AV node during tachycardia.
Topics: Adenosine Triphosphate; Aged; Atrioventricular Node; Cardiac Pacing, Artificial; Diltiazem; Heart Co | 1988 |
The mechanisms of exercise provocation of supraventricular tachycardia.
Topics: Adrenergic beta-Agonists; Adult; Aged; Aged, 80 and over; Digoxin; Drug Therapy, Combination; Electr | 1989 |
Degeneration of junctional tachycardia to pre-excited atrial fibrillation after intravenous verapamil.
Topics: Adult; Atrial Fibrillation; Electrocardiography; Female; Humans; Injections, Intravenous; Tachycardi | 1989 |
Dose of verapamil in neonates and young infants.
Topics: Dose-Response Relationship, Drug; Humans; Infant, Newborn; Infusions, Intravenous; Male; Tachycardia | 1989 |
Repeated intravascular treatment with amiodarone in a fetus with refractory supraventricular tachycardia and hydrops fetalis.
Topics: Adult; Amiodarone; Digoxin; Female; Fetal Diseases; Humans; Hydrops Fetalis; Injections, Intravenous | 1989 |
Continuous verapamil infusion.
Topics: Heart Failure; Humans; Infusions, Intravenous; Tachycardia, Supraventricular; Verapamil | 1989 |
[A case of ectopic junctional tachycardia].
Topics: Adolescent; Electrocardiography; Female; Humans; Tachycardia, Ectopic Junctional; Tachycardia, Supra | 1989 |
Fetal supraventricular tachycardia: detection by routine auscultation and successful in-utero management.
Topics: Female; Fetal Diseases; Humans; Pregnancy; Prenatal Diagnosis; Tachycardia, Supraventricular; Verapa | 1989 |
The excitable gap in atrioventricular nodal reentrant tachycardia. Characterization with ventricular extrastimuli and pharmacologic intervention.
Topics: Atrioventricular Node; Cardiac Pacing, Artificial; Electrocardiography; Electrophysiology; Female; H | 1989 |
'It looks like SVT'--the misuse of intravenous verapamil in broad-complex tachycardia.
Topics: Diagnosis, Differential; Electrocardiography; Humans; Tachycardia; Tachycardia, Supraventricular; Ve | 1989 |
[Incessant supraventricular tachycardia due to upper atrioventricular nodal reentry].
Topics: Adenosine Triphosphate; Aged; Diltiazem; Female; Humans; Male; Tachycardia, Atrioventricular Nodal R | 1989 |
[Electrophysiologic effects of calcium channel blockers on supraventricular tachycardia in children].
Topics: Adolescent; Atrioventricular Node; Calcium Channel Blockers; Child; Child, Preschool; Diltiazem; Ele | 1989 |
Misuse of intravenous verapamil in patients with ventricular tachycardia.
Topics: Adult; Aged; Aged, 80 and over; Diagnostic Errors; Drug Evaluation; Female; Humans; Hypotension; Inf | 1987 |
Atrial automatic tachycardia with two different types of electrophysiologic characteristics.
Topics: Cardiac Pacing, Artificial; Electrocardiography; Female; Heart Atria; Humans; Middle Aged; Tachycard | 1989 |
Epinephrine-induced reversal of verapamil's electrophysiologic and therapeutic effects in patients with paroxysmal supraventricular tachycardia.
Topics: Atenolol; Cardiac Pacing, Artificial; Electrophysiology; Epinephrine; Female; Humans; Male; Middle A | 1989 |
Treatment of paroxysmal supraventricular tachycardia in the emergency department by clinical decision analysis.
Topics: Adult; Aged; Aged, 80 and over; Decision Support Techniques; Digoxin; Electric Countershock; Emergen | 1988 |
Reversible cardiomyopathy following chronic supraventricular tachycardia.
Topics: Adult; Cardiomyopathy, Dilated; Chronic Disease; Digoxin; Drug Combinations; Electrocardiography; Hu | 1988 |
Cardiovascular collapse after verapamil in supraventricular tachycardia.
Topics: Digoxin; Drug Interactions; Humans; Hypotension; Propranolol; Tachycardia, Supraventricular; Verapam | 1988 |
Verapamil administration for acute termination of supraventricular tachycardia in dogs.
Topics: Animals; Dog Diseases; Dogs; Electrocardiography; Heart Rate; Prospective Studies; Tachycardia, Supr | 1988 |
[Use of non-invasive transdermal stimulation of the heart in selecting an anti-arrhythmia drug in a patient with supraventricular paroxysmal tachycardia with a re-entry mechanism within the atrioventricular node].
Topics: Adult; Atrioventricular Node; Cardiac Pacing, Artificial; Heart Conduction System; Humans; Male; Tac | 1988 |
Intravenous verapamil in the home management of supraventricular tachycardia.
Topics: Aged; Female; Humans; Tachycardia, Supraventricular; Verapamil | 1988 |
Verapamil and multifocal atrial tachycardia.
Topics: Humans; Research Design; Tachycardia, Supraventricular; Verapamil | 1988 |
Use of verapamil for paroxysmal supraventricular tachycardia during epidural anesthesia for cesarean section.
Topics: Adult; Anesthesia, Epidural; Cesarean Section; Female; Humans; Tachycardia, Paroxysmal; Tachycardia, | 1988 |
Verapamil-mediated atrioventricular nodal reentrant tachycardia and the uncovering of dual-pathway AV nodal conduction.
Topics: Aged; Angina Pectoris; Atrioventricular Node; Electrocardiography; Heart Conduction System; Heart Ra | 1988 |
Nursing considerations in the administration of verapamil.
Topics: Humans; Tachycardia, Supraventricular; Verapamil | 1988 |
Supraventricular tachyarrhythmias. Mechanisms, types, and management.
Topics: Anti-Arrhythmia Agents; Electric Countershock; Electrocardiography; Electrophysiology; Heart Conduct | 1988 |
MAST application in the treatment of paroxysmal supraventricular tachycardia in a child.
Topics: Child; Electrocardiography; Gravity Suits; Humans; Male; Tachycardia, Supraventricular; Verapamil | 1988 |
Fetal death after successful conversion of fetal supraventricular tachycardia with digoxin and verapamil.
Topics: Adult; Digoxin; Drug Therapy, Combination; Female; Fetal Death; Fetal Diseases; Humans; Pregnancy; T | 1988 |
Type I antiarrhythmic drugs are to be preferred in the treatment of ectopic tachycardias.
Topics: Anti-Arrhythmia Agents; Humans; Tachycardia, Supraventricular; Verapamil | 1988 |
Prehospital use of intravenous verapamil.
Topics: Adult; Aged; Aged, 80 and over; Emergency Medical Services; Female; Humans; Injections, Intravenous; | 1987 |
[Treatment of supraventricular tachyarrhythmias with verapamil following open heart surgery].
Topics: Cardiac Surgical Procedures; Female; Humans; Male; Middle Aged; Tachycardia, Supraventricular; Verap | 1987 |
Cardiovascular collapse after verapamil in supraventricular tachycardia.
Topics: Female; Humans; Hypotension; Infant, Newborn; Male; Tachycardia, Supraventricular; Verapamil | 1987 |
[Successfully treated intractable supraventricular tachycardia after aortic valve replacement with verapamil].
Topics: Aortic Arch Syndromes; Aortic Valve; Aortic Valve Insufficiency; Female; Heart Valve Prosthesis; Hum | 1987 |
Junctional ectopic tachycardia in adults. Role of triggered activity.
Topics: Adult; Humans; Sympathetic Nervous System; Tachycardia, Ectopic Junctional; Tachycardia, Supraventri | 1987 |
The paradoxical adverse effect of verapamil for treating clinical paroxysmal supraventricular tachycardia.
Topics: Adult; Aged; Cardiac Pacing, Artificial; Electrocardiography; Female; Humans; Injections, Intravenou | 1987 |
Failure of episodic high-dose oral verapamil therapy to convert supraventricular tachycardia: a study of plasma verapamil levels and gastric motility.
Topics: Administration, Oral; Adolescent; Adult; Aged; Blood Pressure; Drug Administration Schedule; Female; | 1987 |
PACU vignette: what would you do in this situation?
Topics: Aged; Aortic Aneurysm; Emergencies; Humans; Male; Postoperative Complications; Tachycardia, Supraven | 1986 |
Interactions with cardioactive drugs.
Topics: Aged; Digoxin; Drug Interactions; Female; Humans; Tachycardia, Supraventricular; Verapamil | 1986 |
[Treatment of paroxysmal forms of supraventricular tachycardia with falikard].
Topics: Adult; Aged; Blood Pressure; Drug Evaluation; Female; Heart Rate; Humans; Male; Middle Aged; Tachyca | 1987 |
Intravenous verapamil for treatment of multifocal atrial tachycardia with and without calcium pretreatment.
Topics: Aged; Blood Gas Analysis; Blood Pressure; Calcium; Drug Therapy, Combination; Female; Heart Atria; H | 1987 |
Congestive cardiomyopathy due to chronic tachycardia: resolution of cardiomyopathy with antiarrhythmic drugs.
Topics: Cardiomyopathy, Dilated; Child, Preschool; Digoxin; Drug Therapy, Combination; Electrocardiography; | 1987 |
Insufficient transplacental digoxin transfer in severe hydrops fetalis.
Topics: Adult; Digoxin; Edema; Female; Fetal Diseases; Humans; Maternal-Fetal Exchange; Pregnancy; Propranol | 1987 |
Efficacy of verapamil in the conversion of supraventricular tachycardia in Singapore children.
Topics: Child; Child, Preschool; Digoxin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infa | 1987 |
Supraventricular tachycardia emergencies: diagnosis and management.
Topics: Atrial Fibrillation; Atrial Flutter; Digitalis; Electrocardiography; Electrophysiology; Emergencies; | 1986 |
Verapamil infusions in the treatment of atrial tachyarrhythmias.
Topics: Adult; Aged; Aged, 80 and over; Blood Pressure; Female; Heart Rate; Humans; Infusions, Intravenous; | 1986 |
Supraventricular tachycardia associated with extracorporeal shock wave lithotripsy.
Topics: Aged; Electrocardiography; Female; Humans; Kidney Calculi; Lithotripsy; Middle Aged; Tachycardia, Su | 1986 |
Verapamil in multifocal atrial tachycardia. Hemodynamic and respiratory changes.
Topics: Aged; Electrocardiography; Female; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; | 1987 |
Medicolegal problems in the management of cardiac arrhythmias in children.
Topics: Arrhythmias, Cardiac; Child; Child, Preschool; Humans; Infant, Newborn; Long QT Syndrome; Malpractic | 1987 |
Effects of four antiarrhythmic drugs on the induction and termination of paroxysmal supraventricular tachycardia.
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Disopyramide; Female; Humans; Male; Middle Aged; Pr | 1986 |
[Hydrops fetalis caused by supraventricular tachycardia: effects of the administration of verapamil].
Topics: Edema; Female; Humans; Infant, Newborn; Male; Maternal-Fetal Exchange; Pregnancy; Tachycardia, Supra | 1986 |
An infant fatality following verapamil therapy for supraventricular tachycardia: cardiovascular collapse following intravenous verapamil.
Topics: Humans; Infant; Male; Myocarditis; Shock; Tachycardia, Supraventricular; Verapamil | 1985 |
[Paradoxical response to verapamil. Acceleration of paroxysmal supraventricular tachycardia].
Topics: Adult; Electrocardiography; Female; Heart Rate; Humans; Tachycardia, Paroxysmal; Tachycardia, Suprav | 1985 |